Reply to Letter to the Editor on Mease et al.
Document Type
Article
Publication Date
4-7-2020
Publication Title
Arthritis Rheumatol
Abstract
We read with interest the Letter to the Editor by Kerschbaumer et al regarding our article on the primary results from the SEAM-PsA trial (1). We appreciated the comments highlighting the methotrexate (MTX) monotherapy results. Since MTX is a drug that has been long used in psoriatic arthritis (PsA) without much data from rigorous and well-controlled clinical trials, we sought to provide reliable data about MTX through SEAM-PsA.
Clinical Institute
Orthopedics & Sports Medicine
Department
Rheumatology
Recommended Citation
Mease, Philip; Collier, David H; Kricorian, Gregory; and Chung, James B, "Reply to Letter to the Editor on Mease et al." (2020). Articles, Abstracts, and Reports. 3093.
https://digitalcommons.providence.org/publications/3093
